title: A one-year comparative study of Neoral vs Consupren in de novo renal transplant patients.
authors.affiliation: Rizk Hospital, Beirut, Lebanon.
authors.forename: A
authors.initials: A
authors.lastname: Stephan
authors.forename: M A
authors.initials: MA
authors.lastname: Masri
authors.forename: A
authors.initials: A
authors.lastname: Barbari
authors.forename: S
authors.initials: S
authors.lastname: Aoun
authors.forename: S
authors.initials: S
authors.lastname: Rizk
authors.forename: G
authors.initials: G
authors.lastname: Kamel
mesh_terms: D000961:Antilymphocyte Serum / Q000627:therapeutic use; D016572:Cyclosporine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D004304:Dosage Forms; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy / Q000453:epidemiology; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D015994:Incidence; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality; D008297:Male; D013256:Steroids / Q000627:therapeutic use; D015996:Survival Rate; D013997:Time Factors
chemical_list: D000961:Antilymphocyte Serum; D004304:Dosage Forms; D007166:Immunosuppressive Agents; D013256:Steroids; D016572:Cyclosporine